Guidelines for Diagnosis, Reporting and Management of Intraductal Papillary Neoplasm of the Bile Duct ( IPNB ): Recommendations of Bangkok Consensus Meeting
Open Access
- 18 November 2026
- journal article
- Published by Wiley in Journal of Hepato-Biliary-Pancreatic Sciences
Abstract
Background: There are no international consensus guidelines on IPNB. Method: An international‐multidisciplinary panel performed a critical appraisal of the literature and used a two‐round Delphi process to evaluate 24 critical clinical questions, incorporating community feedback from a dedicated 2025 A‐PHPBA meeting session in Bangkok. Results: Salient aspects of the recommendations: (1) IPNB is analogous to intracholecystic papillary neoplasm (ICPNs)/intraductal papillary mucinous neoplasm (IPMNs), ranging from innocuous cystic lesions to papillary in situ carcinomas to invasive carcinomas. (2) Possible etiologic factors like stones, parasites, PSC, and PBM/choledochal cysts should be assessed in every case. (3) All nonmetastatic IPNBs are candidates for oncologic resection, preferably along with lymph node dissection. (4) Pre‐ and intraoperative assessment for multifocality is important. (5) Liver transplant is a consideration in selected cases. (6) Individualized IPNB‐focused synoptic pathology reports were devised for use. (7) For invasive IPNBs, adjuvant treatment should follow standard cholangiocarcinoma protocols. (8) Follow‐up should mirror main‐duct IPMN protocols, adjusted for invasion and margin status. (9) For isolated IPNB recurrence, resection or transplant is advisable; if infeasible or metastatic, consider ablative and systemic therapies. (10) These recommendations are also applicable to IOPN/ITPN but with subtle differences. Conclusion: These recommendations should aid in cross‐national standardized classification, diagnosis, reporting, and management of IPNBs, and serve as a launching pad for further studies.This publication has 91 references indexed in Scilit:
- Co‐existence of intraductal papillary neoplasm of the bile duct and Opisthorchis viverriniJournal of Hepato-Biliary-Pancreatic Sciences, 2021
- Postoperative adjuvant chemotherapy for resectable cholangiocarcinomaCochrane Database of Systematic Reviews, 2021
- Clinicopathological characteristics of intraductal papillary neoplasm of the bile duct: a Japan‐Korea collaborative studyJournal of Hepato-Biliary-Pancreatic Sciences, 2020
- Randomized clinical trial of adjuvant gemcitabine chemotherapy versus observation in resected bile duct cancerBritish Journal of Surgery, 2018
- A statement by the Japan‐Korea expert pathologists for future clinicopathological and molecular analyses toward consensus building of intraductal papillary neoplasm of the bile duct through several opinions at the present stageJournal of Hepato-Biliary-Pancreatic Sciences, 2017
- Clinical practice guidelines for the management of biliary tract cancers 2015: the 2nd English editionJournal of Hepato-Biliary-Pancreatic Sciences, 2015
- Clinicopathological features and prognosis of mucin‐producing bile duct tumor and mucinous cystic tumor of the liver: a multi‐institutional study by the Japan Biliary AssociationJournal of Hepato-Biliary-Pancreatic Sciences, 2013
- Intraductal papillary neoplasm of the bile duct: A biliary equivalent to intraductal papillary mucinous neoplasm of the pancreas?Hepatology, 2012
- Characterization of Intrahepatic Cholangiocarcinoma of the Intraductal Growth-Type and Its Precursor Lesions *Hepatology, 2005
- Fine-needle aspiration biopsy of hepatic papillary cystadenocarcinoma in Caroli's diseaseDiagnostic Cytopathology, 1992